drugset
Drugs / Salmeterol/Fluticasone Propionate
last change May 2013 re-read 9 days ago

Salmeterol/Fluticasone Propionate

also known as Salmeterol/fluticasone Easyhaler · SF Easyhaler
Developed for
asthma
Investigated by
Orion Corporation, Orion Pharma

Trials 1

today NCT01766843 · Ph 1
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01766843 Jan → May 2013 asthma Orion Corporation, Orion Pharma Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Salmeterol/Fluticasone Propionate “Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind,...” NCT01766843 ↗
Known as Salmeterol/fluticasone Easyhaler “Salmeterol/fluticasone Easyhaler (50/500 mcg/inhalation)” NCT01766843 ↗
Known as SF Easyhaler “Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind,...” NCT01766843 ↗
Route Inhaled “2 inhalations as a single dose” NCT01766843 ↗